VANCOUVER, BC, November 30, 2021 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to formally announce it has signed a lease for its 8th psychedelic assisted psychotherapy (“PAP”) clinic located at 4833 Rugby Avenue, Suite 600, Bethesda, Maryland, 20814.
Located in the same state as prestigious Johns Hopkins University, the Bethesda location will offer 6,092 square feet of space and 10 infusion rooms. The Bethesda clinic is expected to open by December 31, 2021 and offer Revitalist’s full suite of treatments including IV ketamine infusions, vitamin infusions, medication infusions, intensive outpatient programs, ketamine assisted psychotherapy, Spravato, telemedicine therapy sessions and transcranial magnetic stimulation. With 10 treatment rooms, the clinic can provide over 10,400 ketamine infusions to patients annually.
The addition of the Bethesda lease marks the eighth clinic which will increase the total capacity at Revitalist to 53,792 square feet and 109 treatment rooms as detailed below.
Size (Sq Ft)
Clinic Capacity for Treatment Rooms (1)
Johnson City, Tennessee
Raleigh, North Carolina
Knoxville, Tennessee (2nd location)
Estimated based on square footage available in each clinic
Kathryn Walker, CEO, commented, “Maryland is home to a number of important medical, military and research institutions, so gaining a presence in this jurisdiction was an important step in our expansion plan. We look forward to opening the Bethesda location soon and growing our offering of clinics to prospective patients in the United States. Mental health continues to be a national health crisis as rates of anxiety, depression and PTSD keep climbing. Revitalist’s treatments provide important relief and offer hope to those struggling with these illnesses.”
ABOUT REVITALIST LIFESTYLE AND WELLNESS Ltd.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with seven clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here.
On Behalf of the Board
Chief Executive Officer
For further information please contact:
Revitalist Lifestyle and Wellness Ltd.
Tel: (865) 585-8414
Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.